Inactivated Polio Vaccines Broadly Available for the World's Children in the Drive Toward Polio Eradication

PR56024

LYON, France, Mar. 3 /PRN=KYODO JBN/ --

    - Sanofi Pasteur works with global partners to make available unparalleled

quantities of affordable Inactivated Polio Vaccine (IPV) -

    Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE:

SNY), announced today its further commitment to the international community's

efforts to complete polio eradication. UNICEF, the organization that procures

the vaccine to meet global needs, announced it will purchase significant

quantities of Inactivated Polio Vaccine (IPV) from Sanofi Pasteur and make it

available based on country needs and vaccination plans. To achieve the goal of

polio eradication by 2018, the World Health Organization (WHO) recommends that

by end 2015, all children receive routinely at least one dose of IPV in over

120 countries that solely use Oral Polio Vaccine.

    To view the Multimedia News Release, please click:

    http://www.multivu.com/mnr/65021-sanofi-pasteur-inactivated-polio-vaccine

    In order to support rapid and widespread adoption of IPV, Sanofi Pasteur -

the world's largest producer of IPV - and the Bill & Melinda Gates Foundation

have developed a joint price support mechanism, including a financial

contribution from both organizations. This mechanism allows Sanofi Pasteur to

offer IPV at a price of EUR0.75 per dose (approximately US$1) to 73 of the

world's poorest countries. The GAVI Alliance, a global immunisation

partnership, will make IPV available for inclusion in routine immunisation

schedules in these countries.

    This announcement underscores Sanofi Pasteur's commitment to offer

unparalleled volumes of high-quality IPV across a broad range of countries and

economic situations at differential prices in an unprecedented, global rollout.

    http://www.sanofipasteur.com

    http://www.multivu.com/mnr/65021-sanofi-pasteur-inactivated-polio-vaccine

SOURCE: Sanofi Pasteur